Shi, Chaoji
Ju, Houyu
Zhou, Rong
Xu, Shengming
Wu, Yunteng
Gu, Ziyue
Wang, Ying
Chen, Wanling
Huang, Xinyi
Han, Yong
Sun, Shuyang
Li, Chuwen
Wang, Min
Zhou, Guoyu
Zhang, Zhiyuan
Li, Jiang
Ren, Guoxin
Article History
Received: 1 July 2023
Accepted: 20 May 2024
First Online: 29 May 2024
Declarations
:
: The study was registered in the Chinese Clinical Trials Registry Platform (ChiCTR2000031608) and approved by the Ethics Committee of Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine (SH9H-2019-T282-6). Written informed consent was obtained from each patient.
: Not applicable.
: Y. Wang is an employee of Jiangsu Hengrui Pharmaceuticals Co., Ltd. No disclosures were reported by the other authors.The authors declare that they have no competing interests.